Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Life sciences

October 2, 2023 Life sciences / Pharma applications

Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó

This year’s Nobel Prize in physiology or medicine has been awarded to Katalin Karikó and Drew Weissman for their work

Continue reading

two person doing surgery inside room
July 12, 2023 CD derivatives / Diagnosis / Life sciences / Pharma applications

Indocyanine / β-cyclodextrin conjugate enabling imaging of carcinoma tissues upon surgery

Mie University and Nagoya University has jointly developed an Indocyanine / β-cyclodextrin conjugate suitable for ureter visualization in patients undergoing laparoscopic/minimally

Continue reading

May 4, 2023 CD derivatives / Life sciences

Breathtaking anatomical view of a mammalian organism enabled by DIMEB

Science magazine highlights a new method of visualization of organs in such a detail that has never seen before. A

Continue reading

May 1, 2023 CD derivatives / Life sciences / Uncategorized

Cyclodextrin-Based Nanosponges Complexes to Improve Vitamin D Absorption

Vitamin D is important for bone health and helps prevent diseases such as rickets in children and osteomalacia or osteoporosis

Continue reading

April 26, 2023 CD derivatives / Drug delivery / Life sciences

A status of anticancer drug and nutraceutical delivery by cyclodextrin monomers and nanosponges

The COVID-19 pandemic masked the continuous growth of diseases such as cancer. Although the scientific community has studied these diseases

Continue reading

April 18, 2023 CD derivatives / Life sciences / Pharma applications

BioNTech’s new invention: CD as potential cryoprotectant in lipid-based RNA formulation

BioNTech SE has recently (09.09.2022) filed a PCT patent application (WO2023036960, inventors: Hossam Hefesha, Heinrich Haas, Ferdia Bates, Christian Hotz

Continue reading

March 17, 2023 Life sciences

Methyl BCD alters cell envelop studied by AFM

To elucidate the involvement of the cell envelope in the stiffness of sickle cells, methyl-β-cyclodextrin (MβCD), a putative cholesterol-depleting reagent

Continue reading

March 16, 2023 CD as API / CD derivatives / Life sciences / Pharma applications

Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases

RENATUS, a South Korea-based pharma company pioneering next generation cyclodextrin-based therapies for the safe treatment of cholesterol-associated diseases recently filed

Continue reading

microscopic shot of a virus
January 24, 2023 CD as API / Life sciences / Pharma applications

Patent application on reduction of envelope viral particle number in a composition containing cyclodextrin

US patent application US2022409653 entitled “METHOD FOR PREVENTING ENTRY AND REPLICATION OF ENVELOPED VIRUSES” descibes a method for the reduction

Continue reading

January 3, 2023 CD derivatives / Drug delivery / Food / Life sciences

Solvent-free cyclodextrin nanosponges complexes for increasing the bioavailability

Recently the Francesco Trotta’s group of the University of Turin (Italy) has finalized and published the preliminar results that he

Continue reading

Posts navigation

1 2 3 Next Posts»

Recent Posts

  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Cyclodextrin in Vaccines
  • Special Issue “New Advances in Green Extraction Technology for Natural Products”
  • Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
  • Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (17)
  • Analysis (39)
  • CD as API (229)
  • CD derivatives (287)
  • Cosmetics and toilettry (22)
  • Diagnosis (2)
  • Drug delivery (499)
  • E-ducation (59)
  • Environmental (84)
  • Events (167)
  • Food (138)
  • Gene delivery (12)
  • In Hungarian (4)
  • Life sciences (21)
  • Non-pharma applications (250)
  • Other industrial use (74)
  • Pharma applications (783)
  • Supramolecular systems (30)
  • Uncategorized (56)

Top Posts

  • Cyclodextrin in Vaccines
  • BioNTech's new invention: CD as potential cryoprotectant in lipid-based RNA formulation
  • Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins
  • Australian company pioneering Cavadextrin for regression of atherosclerosis
  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Lanosterol eye drops for cataract treatment
  • Ashland webinar — the magic rings: how cyclodextrins can enable drug development
  • How air fresheners work?
  • Curcumin/amphiphilic cyclodextrin nanoassemblies: Theoretical andspectroscopic studies to address their debut in anticancer therapy
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 565 other subscribers
 

Loading Comments...